Etigilimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Etigilimab Usage And Synthesis

Uses

Etigilimab (OMP-313M32), a humanized IgG1 monoclonal antibody, blocks TIGIT interaction with PVR (CD155; poliovirus receptor) and inhibits downstream signalling with target cell killing[1].

References

[1] Meredith McKean, et al. Safety and efficacy of etigilimab in combination with nivolumab in select recurrent/advanced solid tumors.

Etigilimab(2044984-83-8)Related Product Information

• Barzolvolimab
• Alsevalimab
• Immunoglobulin G1,anti-(human CD19 (antigen)) (mouse monoclonal B43 g1-chain), disulfide with mouse monoclonal B43 k-chain, dimer, disulfide withprotein PAP (pokeweed antiviral) (9CI)
• Ivonescimab
• Pimurutamab
• Simridarlimab
• Mezagitamab
• Ligufalimab
• Tabituximab
• Keliximab